TY - JOUR
T1 - Clinical statement on the PBC-AIH overlap 2024 The Intractable Hepato-Biliary Disease Study Group was supported by the Ministry of Health, Labor, and Welfare of Japan
AU - The Working Group for Clinical statement on PBC-AIH overlap 2024
AU - Kugiyama, Yuki
AU - Kawata, Kazuhito
AU - Namisaki, Tadashi
AU - Umemura, Takeji
AU - Komori, Atsumasa
AU - Arinaga, Teruko
AU - Takaki, Akinobu
AU - Takahashi, Atsushi
AU - Ohira, Hiromasa
AU - Harada, Kenichi
AU - Tanaka, Atsushi
N1 - Publisher Copyright:
© 2025 The Japan Society of Hepatology.
PY - 2025
Y1 - 2025
N2 - In clinical practice for autoimmune liver diseases (ALDs), hepatologists occasionally treat patients with overlap syndromes of ALDs with distinct etiologies. Among the various overlap syndromes, the pathology and epidemiology of the primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome remains elusive, with no current consensus on diagnostic and treatment strategies. In the absence of common diagnostic definitions or consensus treatment guidelines for the PBC-AIH overlap syndrome, hepatologists in Japan lack confidence in the treatment of patients with this diagnosis. To address this issue, the Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor, and Welfare of Japan assembled a Working Group to issue the Clinical Statement on the PBC-AIH Overlap Syndrome 2024 for the dissemination of consensus information.
AB - In clinical practice for autoimmune liver diseases (ALDs), hepatologists occasionally treat patients with overlap syndromes of ALDs with distinct etiologies. Among the various overlap syndromes, the pathology and epidemiology of the primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome remains elusive, with no current consensus on diagnostic and treatment strategies. In the absence of common diagnostic definitions or consensus treatment guidelines for the PBC-AIH overlap syndrome, hepatologists in Japan lack confidence in the treatment of patients with this diagnosis. To address this issue, the Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor, and Welfare of Japan assembled a Working Group to issue the Clinical Statement on the PBC-AIH Overlap Syndrome 2024 for the dissemination of consensus information.
KW - autoimmune hepatitis
KW - overlap syndrome
KW - primary biliary cirrhosis
UR - http://www.scopus.com/inward/record.url?scp=85216576082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216576082&partnerID=8YFLogxK
U2 - 10.2957/kanzo.66.1
DO - 10.2957/kanzo.66.1
M3 - Article
AN - SCOPUS:85216576082
SN - 0451-4203
VL - 66
SP - 1
EP - 6
JO - Kanzo/Acta Hepatologica Japonica
JF - Kanzo/Acta Hepatologica Japonica
IS - 1
ER -
